Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Cognetti

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Frontiers in Oncology|December 21, 2020
Discordant Responses Between Primary Head and Neck Tumors and Nodal Metastases Treated With Neoadjuvant Nivolumab: Correlation of Radiographic and Pathologic Treatment EffectDante J Merlino, Jennifer M Johnson, Madalina Tuluc, et al.
Head & Neck|June 6, 2022
Analysis of cost and outcomes in bony versus soft tissue midface free flap reconstructionAngela Alnemri, Ramez Philips, Sarah Sussman, et al.
JAMA Otolaryngology-- Head & Neck Surgery|December 18, 2025
Pathologic Response and Survival After Neoadjuvant Immunotherapy for Resectable Mucosal HNSCC: A Systematic Review and Meta-AnalysisEric V Mastrolonardo, Emma De Ravin, Praneet C Kaki, et al.
Cancer|March 12, 2025
Improved survival with elevated BMI following immune checkpoint inhibition across various solid tumor cancer typesEric V Mastrolonardo, Pablo Llerena, Emma De Ravin, et al.
Head & Neck|October 9, 2021
Phase 1/2a, open-label, multicenter study of RM-1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinomaDavid M Cognetti, Jennifer M Johnson, Joseph M Curry, et al.
Annals of Surgical Oncology|February 12, 2015
[(99m)Tc]Tilmanocept Accurately Detects Sentinel Lymph Nodes and Predicts Node Pathology Status in Patients with Oral Squamous Cell Carcinoma of the Head and Neck: Results of a Phase III Multi-institutional TrialAmit Agrawal, Francisco J Civantos, Kevin T Brumund, et al.
Cancer Medicine|March 23, 2026
Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor of Survival Outcomes in Head and Neck Squamous Cell Carcinoma Receiving Neoadjuvant ImmunotherapyPablo Llerena, Praneet C Kaki, Kathryn Nunes, et al.
The Laryngoscope|November 12, 2024
A Randomized Pilot Trial of Virtual Reality Surgical Planning for Head and Neck Oncologic ResectionKathryn L Nunes, Victor Jegede, Derek S Mann, et al.
Head & Neck|August 25, 2025
Safety and Efficacy Findings From a Phase Ib/II Study of ASP-1929 Photoimmunotherapy With Pembrolizumab in Recurrent and/or Metastatic Head and Neck Squamous Cell CarcinomaDavid M Cognetti, Joseph M Curry, Jennifer Johnson, et al.
Head & Neck|March 22, 2019
Surgical consensus guidelines on sentinel node biopsy (SNB) in patients with oral cancerClare Schilling, Sando J Stoeckli, Maurizio G Vigili, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Frontiers in Oncology|December 21, 2020
Discordant Responses Between Primary Head and Neck Tumors and Nodal Metastases Treated With Neoadjuvant Nivolumab: Correlation of Radiographic and Pathologic Treatment EffectDante J Merlino, Jennifer M Johnson, Madalina Tuluc, et al.
Head & Neck|June 6, 2022
Analysis of cost and outcomes in bony versus soft tissue midface free flap reconstructionAngela Alnemri, Ramez Philips, Sarah Sussman, et al.
JAMA Otolaryngology-- Head & Neck Surgery|December 18, 2025
Pathologic Response and Survival After Neoadjuvant Immunotherapy for Resectable Mucosal HNSCC: A Systematic Review and Meta-AnalysisEric V Mastrolonardo, Emma De Ravin, Praneet C Kaki, et al.
Cancer|March 12, 2025
Improved survival with elevated BMI following immune checkpoint inhibition across various solid tumor cancer typesEric V Mastrolonardo, Pablo Llerena, Emma De Ravin, et al.
Head & Neck|October 9, 2021
Phase 1/2a, open-label, multicenter study of RM-1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinomaDavid M Cognetti, Jennifer M Johnson, Joseph M Curry, et al.
Annals of Surgical Oncology|February 12, 2015
[(99m)Tc]Tilmanocept Accurately Detects Sentinel Lymph Nodes and Predicts Node Pathology Status in Patients with Oral Squamous Cell Carcinoma of the Head and Neck: Results of a Phase III Multi-institutional TrialAmit Agrawal, Francisco J Civantos, Kevin T Brumund, et al.
Cancer Medicine|March 23, 2026
Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor of Survival Outcomes in Head and Neck Squamous Cell Carcinoma Receiving Neoadjuvant ImmunotherapyPablo Llerena, Praneet C Kaki, Kathryn Nunes, et al.
The Laryngoscope|November 12, 2024
A Randomized Pilot Trial of Virtual Reality Surgical Planning for Head and Neck Oncologic ResectionKathryn L Nunes, Victor Jegede, Derek S Mann, et al.
Head & Neck|August 25, 2025
Safety and Efficacy Findings From a Phase Ib/II Study of ASP-1929 Photoimmunotherapy With Pembrolizumab in Recurrent and/or Metastatic Head and Neck Squamous Cell CarcinomaDavid M Cognetti, Joseph M Curry, Jennifer Johnson, et al.
Head & Neck|March 22, 2019
Surgical consensus guidelines on sentinel node biopsy (SNB) in patients with oral cancerClare Schilling, Sando J Stoeckli, Maurizio G Vigili, et al.
Pageof 9